China 1,3-Diacetylbenzene Prices Weaken as Cautious Buying Pressures the Market

According to ChemAnalyst data, 1,3-Diacetylbenzene prices declined by 1.95% month-on-month in July 2026, extending the softer tone that developed as the month progressed. The decline was initially linked to improved availability of acetylation feedstock and lower production cash-cost pressure reported by market participants. Early in July, the restart of idled acetic acid capacity in eastern China improved feedstock availability and reduced the cost pressure faced by producers using acetylation routes. This encouraged sellers of 1,3-Diacetylbenzene to become more flexible in spot negotiations, particularly where buyers were unwilling to accept earlier offer levels. However, the feedstock picture was not uniformly bearish: China’s wider acetic acid market strengthened during the month before weakening toward the end as maintenance units returned to operation.

Supply conditions for 1,3-Diacetylbenzene remained relatively comfortable throughout July. Multipurpose coastal reactors operated at moderate utilization, allowing manufacturers to maintain production without creating a significant shortage in spot availability. The absence of major scheduled shutdowns or prolonged operational disruptions meant that buyers generally had sufficient material to meet immediate requirements. Stable logistics also supported regular movement from production centers to domestic customers and export channels. Shanghai dangerous-goods cargo handling remained operationally manageable, reducing the likelihood that transportation constraints would generate a supply premium for 1,3-Diacetylbenzene. Consequently, producers were increasingly required to compete through negotiations rather than relying on supply tightness to support offers.

Feedstock developments remained an important determinant of 1,3-Diacetylbenzene production economics. Softer coal-linked acetylation costs during portions of the month reduced the cash-cost burden for domestic producers and created room for lower spot bids. At the same time, the broader Chinese acetic acid market experienced a supply-driven tightening phase during the first half of July because of concentrated maintenance, followed by greater availability as plants restarted. This means that the cost outlook for 1,3-Diacetylbenzene remained sensitive to operating rates at upstream facilities. Toluene-derived acetylating agents from overseas suppliers were comparatively stable and did not create a major additional cost shock during July, although changes in international freight, insurance and shipping conditions could alter import economics.

Demand was a more persistent constraint on the 1,3-Diacetylbenzene market. Domestic pharmaceutical-intermediate buyers remained cautious and were reported to be working through inventories accumulated during the second quarter rather than aggressively replenishing stocks. This limited spot enquiries despite continued requirements from pharmaceutical and specialty-chemical manufacturers. China’s broader manufacturing indicators also pointed to weaker purchasing conditions: the official manufacturing PMI fell below the expansion threshold in July, while the new-order index declined, signalling softer market demand. These conditions reduced the incentive for downstream processors to build substantial inventories of 1,3-Diacetylbenzene.

Export demand for 1,3-Diacetylbenzene also softened during July. Shipments toward markets including India, Germany and the United States weakened compared with the preceding month, while Western European buyers showed less urgency in placing fresh orders. Longer negotiations and increased price sensitivity encouraged Chinese traders to offer concessions to secure cargoes. At the same time, international buyers continued to monitor freight costs, geopolitical risks and delivery schedules before committing to larger volumes. This kept export-led support for 1,3-Diacetylbenzene relatively limited.

Looking ahead, the near-term outlook for 1,3-Diacetylbenzene is expected to remain cautious. Continued availability of domestic material, restrained pharmaceutical-intermediate procurement and moderate export enquiries could keep sellers under pressure during the initial part of August. Feedstock movements will remain a critical variable: renewed acetic acid supply after maintenance could keep production costs manageable, while any unexpected upstream shutdown could quickly reverse the cost advantage. The broader acetic acid market’s movement from early-month tightness toward greater availability illustrates how rapidly upstream conditions can change.